There’s no overstating how far we have come since 2000 in the fledgling science of genomics, but at times it has seemed that our ability to amass information has far outstripped our ability to make that information matter by improving healthcare. As extraordinary as the technology is, it cannot get it out of the computer and into clinical practice. Enter Eimear Kenny and Noura Abul-Husn, respectively Founding Director and Clinical Director of the Institute for Genomic Health at the Icahn School of Medicine at Mount Sinai in New York.
More episodes from "The Beagle Has Landed Podcast"
New ACMG Guidelines for Expanded Carrier Screening with Barbara Harrison and Katie StollToday, Laura speaks with Barbara Harrison, Assistant Professor at Howard University (and 2020 NSGC Natalie Weissberger Paul National Achievement Award winner) and Katie Stoll, executive director of Genetic Support Foundation, about the new guidelines from ACMG on expanded carrier screening: how these changes move the field forward, and how they fall short.
Kiran Musunuru Has Good News about Gene Therapy for Common DiseasesA cardiologist and Professor of Medicine at the University of Pennsylvania Perelman School of Medicine, Kiran Musunuru is a clinician and a researcher whose important work has moved the ball forward on gene therapy. As co-founder and scientific advisor to Verve Therapeutics, Kiran has a special perspective – an insider’s view of the business, from someone who is both an academic (MD, PhD, MPH) and a humanist at heart.
Laura and Jordan Brown on New Challenges to Abortion Law and What they Mean for Prenatal DiagnosticsThe legal landscape for abortion is changing rapidly, and in ways that will inevitably affect genetic counseling practice in many states. Joining Laura to discuss the new laws and the role that NSGC can play – if the organization decides that protecting reproductive rights is a priority for its membership-- is Jordan Brown, assistant Director at the genetic counseling program at the Ohio State University, vice chair of the NSGC Public Policy Committee, and a member of the newly formed NSGC Task Force looking at the challenges to reproductive rights.
Jodie Ingles on Cardio GeneticsToday we reach out across closed borders to Australia for a chat with Jodie Ingles, one of the first people anywhere in the world to focus on cardiogenetic counseling. Jodie talks to us about how the field has changed in the last 17 years, and where we are headed next.
Euan Ashley on The Genome OdysseyEuan Ashley has had a front row seat at the genomic revolution, and in his new book The Genome Odyssey he invites us to sit alongside him and watch the show. Even if you lived through it, you won’t believe how quickly things have changed!
Kyle Brothers and Mildred Cho: How to Talk about Race in Designing Genetic ResearchIf you are a clinician, researcher, or editor working in genetics, you are probably aware of the toxic history of our field with regard to race. And (JAMA editors aside, apparently) you are probably aware that this is not just a historical problem, but something affecting medical practice today. How do we move forward in a fashion that is not racist – or, better yet, anti-racist?
Walter Isaacson, "The Code Breaker"Walter Isaacson, who has written biographies that explore the birth of the atomic age (Einstein) and the digital age (Jobs), now turns his attention to the biotech revolution, as embodied by CRISPR pioneer Jennifer Doudna with his new book,
Hank Greely: CRISPR PeopleI can hardly believe I’ve been doing this podcast for more than 2 years and never had Hank Greely on before. Hank Greely is the Deane F. and Kate Edelman Johnson Professor of Law at Stanford University, and Director of the Center for Law and the Biosciences. When you want an opinion on anything at the intersection of law, policy, and bioethics, Hank is where you go. And I want an opinion on everything at the intersection of law, policy, and bioethics. Luckily, Hank’s new book, CRISPR People, brings him on the podcast today.
Eimear Kenny and Noura Abul-Husn: Translational Genomics IncarnateThere’s no overstating how far we have come since 2000 in the fledgling science of genomics, but at times it has seemed that our ability to amass information has far outstripped our ability to make that information matter by improving healthcare. As extraordinary as the technology is, it cannot get it out of the computer and into clinical practice. Enter Eimear Kenny and Noura Abul-Husn, respectively Founding Director and Clinical Director of the Institute for Genomic Health at the Icahn School of Medicine at Mount Sinai in New York.
Diana Bianchi on Prenatal TestingDiana Bianchi began her career in genetics so long ago that she needed to make one thing clear: “I’m not that old. I just started young.” And it’s true! Diana fell in love with the study of chromosomes back in high school and returned to it as a pediatrician and a specialist in neonatal medicine. From the start of her career, she has been absorbed in the question of how to pull information on the fetus from the maternal bloodstream.